ArticleOncoTargets and therapy2013

Fludarabine-based versus CHOP-like regimens with or without rituximab in patients with previously untreated indolent lymphoma: a retrospective analysis of safety and efficacy.

Xiao-Xiao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.